OverweightNCT06658509
Regulation of Different IT on Vascular Function of Overweight Female University Students
A study testing HIIT and SIT in people with Overweight, run by Beijing Sport University at 1 site in China.
Trial summary
This study investigates the effects of different interval training methods, specifically high-intensity interval training (HIIT) and sprint interval training (SIT), on vascular function in overweight female university students. A randomized controlled trial was conducted over an 8-week period. Read more about this study
- Who is it for?
- Ages 18 to 25 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Overweight
- What is being tested?
- HIIT and SIT
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 26 participants
- Where
- 1 siteChina
- Study dates
- 15 Apr 2021to 30 Dec 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Participants aged between 18 and 25 years, female.
- Participants' BMI more than 24 kg·m-2.
- Participants without regular exercise habits.
Who cannot join
- Participants underwent other interventions (e.g., nutrition, psychology, exercise, health education, et al).
- Participants had a history of systematic and professional exercise habit.
- Participants presenced of disease or condition restricting participation, such as injuries, respiratory disease or cardiovascular diseases.
Trial locations and contacts
1 site in 1 country.
China1 site
School of Sports Medicine and Rehabilitation, Beijing Sport University
Beijing
About this study
Official title: Regulation of Different Types of Interval Training on Vascular Function of Overweight Female University Students
This study investigates the effects of different interval training methods, specifically high-intensity interval training (HIIT) and sprint interval training (SIT), on vascular function in overweight female university students. A randomized controlled trial was conducted over an 8-week period.
Read the detailed description
This study aimed to evaluate how different types of interval training (HIIT and SIT) influence vascular function in overweight female university students. Participants were initially enrolled and randomly assigned to HIIT, SIT, or control groups. The participants in HIIT and SIT groups underwent an 8-week supervised exercise program 3 times per week on a treadmill. Both pre- and post-intervention measurements were taken, including vascular function, morphological indicators, and blood markers. This study highlights the potential of interval training as a time-efficient and effective intervention for improving cardiovascular health and body composition in this population.
- Conditions
- Overweight
- Being tested
- HIIT, SIT
- Keywords
- High intensity interval training, Sprint interval training, Overweight, Female, Vascular function
- Medical subject headings
- Overweight
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HIITBehavioural
High-intensity interval training
SITBehavioural
Sprint interval training
| Study group | Role | What they receive |
|---|---|---|
| HIIT group | Experimental | Not described Receives: Behavioral: HIIT |
| SIT group | Experimental | Not described Receives: Behavioral: SIT |
| Control group | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Brachial-ankle pulse wave velocity (baPWV)
The change of baPWV before and after intervention.
Measured: 8 weeks
Ankle-brachial index (ABI)
The change of ABI before and after intervention.
Measured: 8 weeks
Nitric oxide (NO)
The change of NO before and after intervention.
Measured: 8 weeks
Endothelin (ET)
The change of ET before and after intervention.
Measured: 8 weeks
Body weight (BW)
The change of BW before and after intervention.
Measured: 8 weeks
Body mass index (BMI)
The change of BMI before and after intervention.
Measured: 8 weeks
Body fat% (BF%)
The change of BF% before and after intervention.
Measured: 8 weeks
Secondary outcomes (3)
Height
The change of height before and after intervention.
Measured: 8 weeks
Blood pressure (BP)
The change of BP before and after intervention.
Measured: 8 weeks
Maximal oxygen uptake (VO2max)
The change of VO2max before and after intervention.
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Oct 2024
- Study start15 Apr 2021
- Primary completion30 Sep 2021
- Study completion30 Dec 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OverweightStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 26 participants (actual)
Sponsor and investigators
- Lead sponsor
- Beijing Sport University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06658509
- Sponsor's protocol ID
- RODTOITOVFOOFUS
- Status last verified
- Oct 2024
- First submitted
- 24 Oct 2024
- Last updated
- 26 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Regulation of Different Types of Interval Training on Vascular Function of Overweight Female University Students
- ClinicalTrials.gov ID
- NCT06658509
- Acronym / sponsor ID
- RODTOITOVFOOFUS
- Conditions
- Overweight
- Keywords
- High intensity interval training, Sprint interval training, Overweight, Female, Vascular function
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 26 participants (actual)
- Lead sponsor
- Beijing Sport UniversityUniversity, hospital or other
- Study start
- 15 Apr 2021 (actual)
- Primary completion
- 30 Sep 2021 (actual)
- Study completion
- 30 Dec 2021 (actual)
- First posted
- 26 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigates the effects of different interval training methods, specifically high-intensity interval training (HIIT) and sprint interval training (SIT), on vascular function in overweight female university students. A randomized controlled trial was conducted over an 8-week period.
Detailed description
This study aimed to evaluate how different types of interval training (HIIT and SIT) influence vascular function in overweight female university students. Participants were initially enrolled and randomly assigned to HIIT, SIT, or control groups. The participants in HIIT and SIT groups underwent an 8-week supervised exercise program 3 times per week on a treadmill. Both pre- and post-intervention measurements were taken, including vascular function, morphological indicators, and blood markers. This study highlights the potential of interval training as a time-efficient and effective intervention for improving cardiovascular health and body composition in this population.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| HIIT group | Experimental | Behavioral: HIIT |
| SIT group | Experimental | Behavioral: SIT |
| Control group | No intervention | – |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Participants aged between 18 and 25 years, female.
- Participants' BMI more than 24 kg·m-2.
- Participants without regular exercise habits.
Key exclusion criteria (3 listed)
- Participants underwent other interventions (e.g., nutrition, psychology, exercise, health education, et al).
- Participants had a history of systematic and professional exercise habit.
- Participants presenced of disease or condition restricting participation, such as injuries, respiratory disease or cardiovascular diseases.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| HIITHigh-intensity interval training | Behavioural | HIIT group |
| SITSprint interval training | Behavioural | SIT group |
Primary outcome
Brachial-ankle pulse wave velocity (baPWV)
Time frame: 8 weeks
The change of baPWV before and after intervention.
Ankle-brachial index (ABI)
Time frame: 8 weeks
The change of ABI before and after intervention.
Nitric oxide (NO)
Time frame: 8 weeks
The change of NO before and after intervention.
Endothelin (ET)
Time frame: 8 weeks
The change of ET before and after intervention.
Body weight (BW)
Time frame: 8 weeks
The change of BW before and after intervention.
Body mass index (BMI)
Time frame: 8 weeks
The change of BMI before and after intervention.
Body fat% (BF%)
Time frame: 8 weeks
The change of BF% before and after intervention.
3 secondary outcomes
Height
Time frame: 8 weeks
Blood pressure (BP)
Time frame: 8 weeks
Maximal oxygen uptake (VO2max)
Time frame: 8 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2024.
- Individual participant dataSharing planned: No
Related trials for Overweight
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing HIIT and SIT in people with Overweight, run by Beijing Sport University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Brachial-ankle pulse wave velocity (baPWV) (time frame: 8 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2024.